Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.24.0.1
Earnings Per Share (Tables)
6 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of the calculation of basic and diluted earnings per share

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Quarter Ended

Six Months Ended

December 31, 

December 31, 

    

2023

    

2022

2023

    

2022

Earnings per share – basic:

Net earnings, including noncontrolling interest

$

27,465

 

$

50,005

$

78,459

 

$

139,739

Less net earnings (loss) attributable to noncontrolling interest

 

 

179

Net earnings attributable to Bio-Techne

$

27,465

$

50,005

$

78,459

$

139,560

Income allocated to participating securities

 

(3)

 

(10)

 

(13)

 

(35)

Income available to common shareholders

$

27,462

$

49,995

$

78,446

$

139,525

Weighted-average shares outstanding – basic

 

157,533

 

157,011

 

157,826

 

156,887

Earnings per share – basic

$

0.17

$

0.32

$

0.50

$

0.89

Earnings per share – diluted:

 

  

 

  

 

  

 

  

Net earnings, including noncontrolling interest

$

27,465

$

50,005

$

78,459

$

139,739

Less net earnings (loss) attributable to noncontrolling interest

179

Net earnings attributable to Bio-Techne

$

27,465

$

50,005

$

78,459

$

139,560

Income allocated to participating securities

 

(3)

 

(10)

 

(13)

 

(35)

Income available to common shareholders

$

27,462

$

49,995

$

78,446

$

139,525

Weighted-average shares outstanding – basic

 

157,533

 

157,011

 

157,826

 

156,887

Dilutive effect of stock options and restricted stock units

 

2,527

 

4,739

 

3,175

 

4,879

Weighted-average common shares outstanding – diluted

 

160,060

 

161,750

 

161,001

 

161,766

Earnings per share – diluted

$

0.17

$

0.31

$

0.49

$

0.86